199 related articles for article (PubMed ID: 19953936)
1. [Correlation of a disintegrin and metalloprotease 12 level in maternal serum during the first trimester with pregnancy outcome].
Qi H; Bian XM; Jiang YL; Liu SY; Guo Q
Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):401-4. PubMed ID: 19953936
[TBL] [Abstract][Full Text] [Related]
2. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
3. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
Poon LC; Chelemen T; Granvillano O; Pandeva I; Nicolaides KH
Obstet Gynecol; 2008 Nov; 112(5):1082-90. PubMed ID: 18978109
[TBL] [Abstract][Full Text] [Related]
4. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
Spencer K; Cowans NJ
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
[TBL] [Abstract][Full Text] [Related]
6. ADAM12: a novel first-trimester maternal serum marker for Down syndrome.
Laigaard J; Sørensen T; Fröhlich C; Pedersen BN; Christiansen M; Schiøtt K; Uldbjerg N; Albrechtsen R; Clausen HV; Ottesen B; Wewer UM
Prenat Diagn; 2003 Dec; 23(13):1086-91. PubMed ID: 14691998
[TBL] [Abstract][Full Text] [Related]
7. [Second trimester screening for trisomy 21 using ADAM12-S as a maternal serum marker].
Jiang T; Lv L; Yang B; Sun YJ; Zhang XJ; Sun Y; Xu QJ; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):314-8. PubMed ID: 22678798
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum ADAM-12 as a potential marker for different adverse pregnancy outcomes.
Matwejew E; Cowans NJ; Stamatopoulou A; Spencer K; von Kaisenberg CS
Fetal Diagn Ther; 2010; 27(1):32-9. PubMed ID: 20090292
[TBL] [Abstract][Full Text] [Related]
9. ADAM12s in maternal serum as a potential marker of pre-eclampsia.
Spencer K; Cowans NJ; Stamatopoulou A
Prenat Diagn; 2008 Mar; 28(3):212-6. PubMed ID: 18264967
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.
Yang J; Wu J; Guo F; Wang D; Chen K; Li J; Du L; Yin A
PLoS One; 2014; 9(5):e97284. PubMed ID: 24830297
[TBL] [Abstract][Full Text] [Related]
11. ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome.
Christiansen M; Spencer K; Laigaard J; Cowans NJ; Larsen SO; Wewer UM
Prenat Diagn; 2007 Jul; 27(7):611-5. PubMed ID: 17465398
[TBL] [Abstract][Full Text] [Related]
12. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.
Cowans NJ; Spencer K
Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174
[TBL] [Abstract][Full Text] [Related]
13. First trimester maternal serum ADAM12s levels in twin pregnancies.
Linskens IH; Twisk JW; Blankenstein MA; van Vugt JM
Prenat Diagn; 2010 Apr; 30(4):352-6. PubMed ID: 20187159
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestation.
Laigaard J; Cuckle H; Wewer UM; Christiansen M
Prenat Diagn; 2006 Aug; 26(8):689-91. PubMed ID: 16752438
[TBL] [Abstract][Full Text] [Related]
16. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
Donalson K; Turner S; Wastell H; Cuckle H
Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of biochemical marker ADAM-12 at first trimester of pregnancy for hypertension and intrauterine growth restriction.
Kasimis C; Evangelinakis N; Rotas M; Georgitsi M; Pelekanos N; Kassanos D
Clin Exp Obstet Gynecol; 2016; 43(1):43-7. PubMed ID: 27048016
[TBL] [Abstract][Full Text] [Related]
18. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum ADAM12s as a marker of rare aneuploidies in the first or second trimester of pregnancy.
Spencer K; Cowans NJ; Stamatopoulou A
Prenat Diagn; 2007 Dec; 27(13):1233-7. PubMed ID: 17987603
[TBL] [Abstract][Full Text] [Related]
20. ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
Wang M; Lu S; Zhu Y; Li H
Prenat Diagn; 2010 Jun; 30(6):561-4. PubMed ID: 20509157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
